5-5-5 Zone – We won’t be left behind! at AIDS 2024 conference: Call for Proposals

The European AIDS Treatment Group (EATG) together with AIDS Action Europe (AAE) and Correlation – European Harm Reduction Network (C-EHRN) are issuing this Call for Participation in “5-5-5 – We won’t be left behind!”, a networking zone in the Global Village at the 25th International AIDS Conference (22 July – 26 July 2024) in Munich, Germany.

Please carefully read the application details before submitting your application. Click here to submit your application: https://forms.office.com/e/bL7xzEMVvq

Application deadline 23 May 2024, 23:59 CET. 

Unfortunately, we are not able to provide financial support for presenters or participants. Organisers must find their own funding for travel to Munich, Germany and all costs associated with participation in AIDS 2024. For more information about the conference visit: www.aids2024.org.

Entry to the Global Village is free and open to the public. It does not require the payment of a conference registration fee.

If you have any questions, please contact Chiara Longhi (chiara.longhi@eatg.org).

 


Objectives

The 5-5-5 – We won’t be left behind! zone will examine gaps and solutions to achieve the 95% targets, and how to reach the remaining 5% with a focus on the WHO European region (partners beyond the region are welcome to apply). There will be one theme per day with inspirational talks, presentations, and recaps on key learnings.

The objectives are:

  1. To foster and strengthen cross-sectional and cross-country collaborations by providing a space for mutual-learning and networking together means for them.
  2. To strengthen the inclusivity and participatory nature of HIV related organisations by consulting communities on what meaningful engagement.
  3. To strengthen and sharpen advocacy initiatives, by providing a space to discuss communities’ advocacy priorities, challenges, and ways to work.

The zone will provide space for community organisations to organise sessions around 5 themes. The overarching themes will be to address stigma and discrimination, improve health outcomes of inadequately served populations and social justice.

Thematic days:

  1. Mobility and HIV (21 July).
  2. Sexuality and sex positive approaches (22 July).
  3. Well-being, quality of life and mental health (23 July).
  4. Substance use and harm reduction (24 July).
  5. Blind spots in the HIV response (25 July).

Who can apply?

We are calling for participation from grassroots and national NGOs, community-based organisatios, networks, researchers, institutions, civil society organisations, human rights organisations, advocacy associations for people living with HIV and other social justice organisations, as well as leaders in the field of HIV from around the WHO European region to join us in advancing the above objectives. Partners beyond the region are welcome to apply.

In our networking zone, we are particularly looking for applications from people living with HIV and other co-infections, trans and gender-diverse people, migrants and people on who move, women, people who use drugs and people in prisons and closed settings.

Activities

We invite you to apply to host an activity related to one the thematic days (Mobility and HIV; Sexuality and sex positive approaches; Well-being, quality of life and mental health; Substance use and harm reduction; Blind spots in the HIV response) including, but not limited to, the following types:

  1. Posters, presentations and discussions
  2. Demonstrations of innovative advocacy or equity initiatives
  3. Display of art projects
  4. Presentations of new research findings and evidence
  5. Interactive skills-building sessions and workshops
  6. Film screenings and digital storytelling
  7. Stories from community representatives
  8. Presentation of policy papers and community resources
  9. Roundtable discussions with key stakeholders in the field of HIV, viral hepatitis, and STIs
  10. Facilitated networking events

Interview with Alice Pomfret | City Reports

The City Reports are the final segment of Correlation – European Harm Reduction Network (C-EHRN)’s Civil Society-led Monitoring of Harm Reduction 2023 Data Report. These concise harm reduction ‘case studies’ highlight either innovative practices or urgent issues demanding immediate attention in five different European cities. The reports will serve as advocacy tools to engage decision makers at all levels, either by showcasing best practices or as an urgent call to action. We asked the primary author, Alice Pomfret, about the process of preparing the reports, and how harm reduction organisations can use them in their advocacy efforts. Read the interview below!

Why did you decide to dedicate a volume of the 2023 monitoring report to the city reports?

The city reports are highly qualitative in nature, and they really zoom in to one particular issue or practice to provide a more nuanced understanding of the local context. We have found that traditional methods such as surveys and questionnaires, while great for capturing large amounts of data, are not so effective at achieving that level of depth. The city reports offer selected focal points an opportunity to authentically tell their story and shed light on issues that are unique to their cities. We hope that this will raise greater awareness of the particular issue, strengthening their advocacy efforts and ultimately leading to positive change.

How did you choose the cities that were included in the report series?

Focal points were invited to nominate themselves to be involved in the City Reports, and following a series of meetings, five cities were selected. This selection process involved extensive discussions with the focal points themselves, leading to a collaborative decision of the cities to be featured. A mix of capital cities and smaller cities were chosen to reflect a variety of contexts, populations and needs. We also thought about geographical variation to ensure coverage across regions. Additionally, we took into account whether the situation that they wished to share were examples of innovative practices or urgent problems to ensure that the reports were balanced in that respect too. It was important for us to strike a balance between positive and negative aspects so that we don’t just focus on the ‘doom and gloom’ and celebrate some harm reduction wins along the way.

Which methods did you use to collect the data for the city reports?

Semi-structured interviews were conducted with various stakeholders, including community representatives, policymakers, harm reduction service providers, and other relevant actors. Depending on the city, interviews were either conducted in the local language by the focal point, then translated into English, and analysed by myself. Or, where respondents were comfortable interviewing in English, I would conduct and analyse the interviews myself. I also gathered extensive literature on the topic to supplement the interviews.

How can harm reduction organisations make use of the city reports?

The reports have been designed to function as concise and easily accessible advocacy tools, aimed at engaging decision makers at various levels. They achieve this by either showcasing best practices, offering inspiration for other cities, or by highlighting an urgent problem that requires immediate attention and action. We purposely tried to keep these reports short and to the point, so that they are more likely to actually be read by decision-makers. The design of the report was influenced by input from the focal point, aligning them closely with their specific needs and goals. However, other harm reduction organisations can definitely use the reports. For instance, to benchmark their own city against other cities’ approaches, or alternatively, if they are experiencing challenges similar to those highlighted in a report, they can use them as resources to strengthen their own advocacy initiatives.

C-EHRN will also establish and implement a tailored Advocacy Mentorship Programme to increase the advocacy capacities of focal points and support the dissemination of C-EHRN reports and activities at the local and national policy-making levels. This will include a tailored advocacy training coordinated by the Rights Reporter Foundation and follow-up mentorship support for focal points who were involved in the City Reports for 2023. It will also involve a video being produced, with the findings presented at the European Harm Reduction Conference in December, which is really exciting!

Have you noticed any significant differences among the cities and if so, would you describe what these were?

What’s been really interesting to see across cities is how local and national politics play out differently when it comes to supporting harm reduction efforts. For instance, in Esch-sur-Alzette in Luxembourg, harm reduction initiatives, including the implementation of drug consumption rooms (DCRs), are a key part of the National Drug Strategy. So, any pushback against DCRs usually comes from the local level, so the city municipalities. Whereas in Warsaw, we see greater engagement from the local policymakers, at least at the district level, whereas decision makers higher up, whether at the city level or national level, seem to prioritise drug policy or harm reduction less. A similar dynamic can also be seen in Amsterdam, where the city government is extremely progressive, openly criticising the failures of the war on drugs, and advocating for drug regulation. Yet at the national level, the stance on drug policy remains much more in this prohibitionist paradigm.

 

Following a new format, Correlation – European Harm Reduction Network’s Civil Society-led Monitoring of Harm Reduction in Europe 2023 Data Report is launched in 6 volumes: Hepatitis C CareEssential Harm Reduction ServicesNew Drug TrendsMental Health of Harm Reduction StaffTEDI Reports and City Reports (WarsawBălţiEsch-sur-AlzetteLondonAmsterdam). The Executive Summary can be accessed here.

Recording – City Report Launch | Civil Society Monitoring of Harm Reduction in Europe

The video is the recording of the report launch webinar that took place on Tuesday, 9th April 2024.

The City Reports are the final segment of Correlation – European Harm Reduction Network (C-EHRN)’s Civil Society-led Monitoring of Harm Reduction 2023 Data Report. These concise harm reduction ‘case studies’ highlight either innovative practices or urgent issues demanding immediate attention in five different European cities. The reports will serve as advocacy tools to engage decision makers at all levels, either by showcasing best practices or as an urgent call to action.

Panellists:

 

Following a new format, Correlation – European Harm Reduction Network’s Civil Society-led Monitoring of Harm Reduction in Europe 2023 Data Report is launched in 6 volumes: Hepatitis C CareEssential Harm Reduction ServicesNew Drug TrendsMental Health of Harm Reduction StaffTEDI Reports and City Reports (WarsawBălţiEsch-sur-AlzetteLondonAmsterdam). The Executive Summary can be accessed here.

City Report – Bălţi. Violating confidentiality: The disclosure of medical data of people who use drugs

In Bălţi, Moldova’s second-largest city, the prevalence of HIV and HCV among people who inject drugs in Bălţi is disproportionately high. Despite the presence of harm reduction services throughout Bălţi, accessibility to these services remains a key problem. Barriers, including inadequate psychosocial support, employment and travel constraints, and fear of discrimination, hinder participation in treatment and harm reduction services. A notably prominent barrier is the pervasive stigma and discrimination exhibited by healthcare staff towards key populations, deeply rooted within healthcare settings. Approximately one quarter of people who inject drugs avoid medical care and HIV/HCV testing due to fears about their drug use becoming known. This is linked to healthcare personnel disclosing sensitive medical information such as a person’s HIV status, which can lead to stigma, discrimination and even dismissal from employment. It also hinders access to HIV services and breeds mistrust in the wider health system. Legal restrictions criminalising HIV exposure and transmission, drug use, and certain sexual activities further obstruct safe behaviours and service access. Though a national network of specialist paralegals established in 2017 has helped to bring justice to affected individuals, addressing these issues at their core is crucial for systemic, lasting change.

 

Following a new format, Correlation – European Harm Reduction Network’s Civil Society-led Monitoring of Harm Reduction in Europe 2023 Data Report is launched in 6 volumes: Hepatitis C CareEssential Harm Reduction ServicesNew Drug TrendsMental Health of Harm Reduction StaffTEDI Reports and City Reports (WarsawBălţiEsch-sur-AlzetteLondonAmsterdam). The Executive Summary can be accessed here.

Launch of the City Reports | A New Addition to the C-EHRN Civil Society-Led Monitoring of Harm Reduction in Europe 2023

To mark the publication of the City Reports, we invite you to join our webinar on Tuesday, 9th April, 12:00 (CEST/Amsterdam time).

The City Reports are the final segment of Correlation – European Harm Reduction Network (C-EHRN)’s Civil Society-led Monitoring of Harm Reduction 2023 Data Report. These concise harm reduction ‘case studies’ highlight either innovative practices or urgent issues demanding immediate attention in five different European cities. The reports will serve as advocacy tools to engage decision makers at all levels, either by showcasing best practices or as an urgent call to action.

During the webinar, primary author Alice Pomfret will be joined by the five representatives of the participating focal points to delve into the findings and discuss the next steps for advocacy based on the reports’ conclusions. Participants are invited to engage in an interactive Q&A session.

 

Panellists:

 

 

Following a new format, Correlation – European Harm Reduction Network’s Civil Society-led Monitoring of Harm Reduction in Europe 2023 Data Report is launched in 6 volumes: Hepatitis C CareEssential Harm Reduction ServicesNew Drug TrendsMental Health of Harm Reduction StaffTEDI Reports and City Reports (WarsawBălţiEsch-sur-AlzetteLondonAmsterdam). The Executive Summary can be accessed here.

Watch the short film introducing CORE – COmmunity REsponse to End Inequalities!

Introducing CORE – COmmunity REsponse to End Inequalities!
 
Uniting the efforts of 24 partners from 16 countries, CORE puts community responses in the centre, empowering them to scale up the services and lead HIV, HCV, and TB responses. In this introductory film, CORE partners talk about the situation and challenges with community response and their expectations for the 3 years of the project.
 
 

Digital Skills Training Course for Organisations Working in HIV & Viral Hepatitis

As part of the BOOST project, a Digital Skills Training for harm reduction organisations working in the area of HIV and viral hepatitis will be held between February and March. The course aims to build the capacity of community-based & community-led harm reduction organisations to use digital tools in the area of HIV and viral hepatitis services.

Find the course sessions, dates, and registration link for each session below:

Can’t attend all the sessions? Please note that joining only one of the sessions is also possible! You can register for each session you’re interested in separately through the respective link.

Collaborative Steps: Crafting a Joint European Advocacy Strategy for Improved HIV, HCV and TB Services for People Who Use Drugs

On 30 and 31 January 2024, partners of Correlation – European Harm Reduction Network and the BOOST Project met in Amsterdam to discuss the development of a European advocacy strategy to ensure access to comprehensive HIV, HCV and TB services for people who use drugs in Europe.

The development of a Joint European Advocacy Strategy is unique as it will be supported and implemented by 4 European Networks, including Correlation – European Harm Reduction Network (C-EHRN), the Eurasian Harm Reduction Association (EHRA), the European Network of People Who Use Drugs (EuroNPUD) and Drug Policy Network South East Europe (DPNSEE) and is based on a broad European consultation of nearly 100 experts and members of the different networks.

4-5 Advocacy Priorities and related Advocacy Objectives are identified during the Amsterdam meeting, covering the forthcoming 5 years (2024-2028). The final Strategy is expected to be launched and published in March 2024 and will be implemented with the support of a broader network of European harm reduction and drug policy organisations.

The Amsterdam meeting is part of a greater trajectory of the advocacy activities in the multi-annual BOOST Project. The results will feed into follow-up activities, including the organisation of Policy Webinars, a European Policy Dialogue Meeting during the European Harm Reduction Conference 2024 and the preparation of a series of Policy Papers.

In February, the networks will launch a call for local harm reduction services to support the development and implementation of Local Advocacy Plans in 6 countries/cities.

 

The Amsterdam meeting was co-organised by C-EHRN (coordinator of the BOOST Project) and EHRA, in close cooperation with EuroNPUD and DPNSEE.

Open Call for Trainers – Workshop Series for Community-led Communicable Diseases Services

We are excited to announce an open call for trainers for Project CORE‘s Workshop Series!

 

Project CORE – “Community Response to End Inequalities” focuses on reducing inequalities in HIV, TB, and viral hepatitis response by promoting, strengthening, and integrating community responses that have proven key in reaching vulnerable communities. We are looking for trainers to lead workshops within Work Package 4, which aims to strengthen the capacity of Community Health Workers and peers to conduct community-led interventions for those experiencing intersectional vulnerabilities to scale up testing services. The workshop series will be organised by Deutsche Aidshilfe in cooperation with Africa Advocacy FoundationEuropean Sex Workers’ Rights Alliance and C-EHRN in an online format from March 2024 until September 2024.
 
The workshops will focus on the following key topics:
1. Key Populations in HIV/HCV prevention and care
2. Culturally competent services
3. Legal and Policy Landscape
4. Overcoming Barriers
5. Sustainability of services
6. Mental health
 
Trainers are expected to:
  • Deliver a detailed, experience-based presentation.
  • Facilitate discussions where peers and community health workers can exchange experiences and best practices.
  • Establish feedback mechanisms for participant input.
  • Encourage an inclusive and respectful environment for open dialogue.
  • Ensure workshops stay on schedule and cover all relevant agenda items.
  • Synthesize the key points and outcomes of the meeting for future reference and reporting.

Responsibilities:

  • Developing workshop content based on the specified theme.
  • Conducting interactive and engaging online workshops.
  • Facilitating discussions, activities, and exercises.
  • Providing constructive feedback and support to participants.
 
The ideal trainer should possess the following qualifications and expertise:
  • Strong knowledge of HIV/HCV/TB prevention strategies, particularly in diversity and intersectionality.
  • Experience in moderating meetings and facilitating discussions on sensitive topics.
  • Excellent communication and interpersonal skills.
  • Sensitivity to cultural, social, and gender-related issues, and a commitment to ensuring inclusive participation.
  • Strong organisational skills and effective time management.
  • Proficiency in spoken English.
 
Application process:

For detailed information, read the Terms of Reference!
To apply, please fill in this online form.
You can apply as a trainer for more than one topic.

Looking forward to receiving your applications!

Insights from HepHIV2023 Conference: Addressing Stigma, Testing, and Integration in HIV and Hepatitis Services

The HepHIV2023 conference, held in Madrid, Spain, from 13th to 15th November, convened a diverse array of stakeholders committed to advancing the fight against HIV, viral hepatitis and sexually transmitted infections (STIs). The event was organized by EuroTEST, and our Senior Policy Officer, Roberto Pérez Gayo, also participated in its organising committee. The conference spotlighted pivotal themes in the realm of infectious diseases, with a focus on integrated testing, technological advancements, and equitable service delivery.

Rafaela Rigoni, C-EHRN’s Scientific Officer, offers key takeaways from the conference, emphasizing critical issues surrounding HIV, and highlighting the conference’s focus on testing, migration, and stigma.

Stigma emerged as a central point of discussion, drawing attention to the multifaceted dimensions impacting individuals living with HIV (PLHIV) and at-risk communities. The targets for 2025 established by UNAIDS to ensure that less than 10% of these groups would be subjected to stigma and discrimination spurred collaborative efforts to develop monitoring mechanisms. Notably, the collaboration between the European Centre for Disease Prevention and Control (ECDC), European AIDS Treatment Group (EATG) and AIDS Action Europe led to the creation of an instrument based on the HIV Stigma Index to measure stigma.

Insights in a recently published report using the HIV stigma survey showed that despite participants generally rating their overall quality of life as satisfactory, there is a prevalent connection between stigma and depression. This critical correlation between stigma and mental health, particularly depression, emphasises the need for enhanced mental health services tailored to the unique needs of the population living with HIV.

Moreover, the survey shed light on the alarming prevalence of self-stigma, indicating that individuals harboured negative perceptions about themselves, along with instances of stigma from family and friends. Notably, healthcare settings emerged as hotspots for heightened stigma. Those reporting lower life quality consistently reported more profound experiences of stigma, highlighting the pressing need for targeted interventions to address and mitigate these challenges. The need to understand the experiences of different key populations and research the intersectionality around stigma was highlighted.

The conference didn’t solely focus on HIV; the first attempts to develop a monitoring instrument to measure HCV-related stigma are also underway by ECDC, and C-EHRN was invited to be part of an expert group with an advisory role, fulfilled by our Senior Scientific Officer.

 

More about HepHIV

The conference brings together stakeholders from all levels of the health system, from community organisations to health care providers and policymakers to present and discuss new approaches for testing and linkage to care for HIV, viral hepatitis, sexually transmitted infections (STIs) and tuberculosis (TB), highlighting programmatic/ implementation issues and adaptation of testing services in response to emerging public health issues.  Frontline workers constituted the majority of participants, highlighting the practical implications of the discussions for those directly involved in service delivery.

In summary, the conference illuminated the complexities surrounding stigma, emphasized the critical intersections between mental health and stigma, and underscored the importance of tailored interventions. Moreover, it highlighted the imperative need for integrated testing approaches and the adaptation of services to address emerging public health challenges.